Hello, Guest!
  • Thursday, November 21, 2024

Oracle Closes Cerner Purchase

Austin, Texas-based software provider Oracle (NYSE: ORCL) announced that its acquisition of Cerner (Nasdaq: CERN) will close on Wednesday, June 8, after a majority of the Missouri-based health information technology maker’s outstanding shares were validly tendered.

American Stock Transfer & Trust Co., the depositary for the tender offer, noted that 69.2 percent of the total shares, or about 204,280,589 shares, were validly tendered at the end of Monday, June 6, Oracle said Tuesday.

On June 1, Oracle announced that it secured European Commission clearance and other antitrust approvals required for its proposed acquisition of Cerner.

In December, Oracle agreed to buy Cerner through an all-cash tender offer valued at approximately $28.3 billion, or $95.00 per share, to expand its presence in the health care IT market.

Video of the Day

Related Articles

Oracle Gets Antitrust Approvals for Proposed Cerner Acquisition M&A Activity

Oracle Gets Antitrust Approvals for Proposed Cerner Acquisition

Oracle (NYSE: ORCL) has received European Commission clearance and other antitrust approvals required for the company’s proposed acquisition of Missouri-based health information technology maker Cerner (Nasdaq: CERN). Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer in December and the Austin, Texas-based software provider said Wednesday it expects the tender

Oracle Extends Tender Offer in Connection to Cerner Buy M&A Activity

Oracle Extends Tender Offer in Connection to Cerner Buy

Oracle (NYSE: ORCL) has once again extended its tender offer of $95 in cash per share to buy all outstanding shares of common stock of health information technology company Cerner (Nasdaq: CERN) to provide more time to satisfy the remaining conditions. Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer

Oracle Clears Waiting Period Under Antitrust Law for Cerner Acquisition M&A Activity

Oracle Clears Waiting Period Under Antitrust Law for Cerner Acquisition

The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for the proposed acquisition of health information technology company Cerner (Nasdaq: CERN) by Oracle (NYSE: ORCL) expired Tuesday, Feb. 22. Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer in late December and both parties expect the tender offer